APA (7th ed.) Citation

Huang, Y., Chen, M., Wei, Y., Cai, B., Zhang, Y., Lin, C., . . . Zheng, B. (2025). Tumor Regression Grade as a Predictor of Adjuvant Therapy Benefits in Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Therapy. Cancer Medicine, 14(18), 1. https://doi.org/10.1002/cam4.71166

Chicago Style (17th ed.) Citation

Huang, Yizhou, et al. "Tumor Regression Grade as a Predictor of Adjuvant Therapy Benefits in Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Therapy." Cancer Medicine 14, no. 18 (2025): 1. https://doi.org/10.1002/cam4.71166.

MLA (9th ed.) Citation

Huang, Yizhou, et al. "Tumor Regression Grade as a Predictor of Adjuvant Therapy Benefits in Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Therapy." Cancer Medicine, vol. 14, no. 18, 2025, p. 1, https://doi.org/10.1002/cam4.71166.